Judy Slinn
Biographic Data
| ID | 1113901 |
|---|---|
| NAME | Judy Slinn |
| GIVEN NAMES | Judy |
| FAMILY NAME | Slinn |
| SIGNATURE | SLINN J |
| AFFILIATIONS | Oxford Brookes University |
| VERIFIED | No |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 11 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1989 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 1 |
Glaxo
The Commonwealth III
The background and the market South Africa provides an interesting case of a market in which Glaxo Laboratories made a considerable effort in the 1940s and 1950s, largely at the instigation of Jephcott and under the influence of his loyalty to the Commonwealth Dominions. At that time British multinational investment in South Africa was particularly successful, but political factors and other local characteristics resulted in a gradual diminution …
Medicating Modern America
Reviewed by: Medicating Modern America: Prescription Drugs in History Judy Slinn (bio) Medicating Modern America: Prescription Drugs in History. Edited by Andrea Tone and Elizabeth Siegel Watkins. New York: New York University Press, 2007. Pp. vi+262. $70/$22. The exponential growth of the pharmaceutical industry in the second half of the twentieth century has been a significant international phenomenon offering a rich area for exploration by his…
Burroughs Wellcome & Co
Patents and the UK pharmaceutical industry between 1945 and the 1970s
The years following the end of World War II saw a rapid increase in the rate of the introduction of new products by the pharmaceutical industry in Europe and North America. Patenting played an increasingly significant role in the industry and the companies, which were investing heavily in research, needed to develop strategies of appropriation to ensure that they recouped the rewards of innovation. This paper explores the use of patents by UK com…
Prescribing by Numbers
Price Controls or Control through Prices? Regulating the Cost and Consumption of Prescription Pharmaceuticals in the UK, 1948–67
Pharmaceutical Innovation
This book sets out to explore the historical evolution of the pharmaceutical industry over the last 150 years, identifying the major discoveries and evaluating them in terms of their scientific novelty, their economic value, and their significance for human health. Its main focus is on the second half of the twentieth century, when the pace of innovation in the industry has been most rapid. In that time frame the large U.S. corporations--based in…
Innovation at Glaxo and May & Baker, 1945–1965
In the two decades after the end of the second world war the UK pharmaceutical industry failed to match its international competitors in innovation, as measured by the number of patented new drag introductions. This paper explores, through a perspective on two companies in the UK, Glaxo Laboratories and May 8c Baker, the failure to innovate significantly. It examines the research and development facilities in the companies, the resources they (an…
Glaxo
Linklaters and Paines
Linklaters and Paines
Glaxo
Innovation at Glaxo and May & Baker, 1945–1965
In the two decades after the end of the second world war the UK pharmaceutical industry failed to match its international competitors in innovation, as measured by the number of patented new drag introductions. This paper explores, through a perspective on two companies in the UK, Glaxo Laboratories and May 8c Baker, the failure to innovate significantly. It examines the research and development facilities in the companies, the resources they (an…
Pharmaceutical Innovation
This book sets out to explore the historical evolution of the pharmaceutical industry over the last 150 years, identifying the major discoveries and evaluating them in terms of their scientific novelty, their economic value, and their significance for human health. Its main focus is on the second half of the twentieth century, when the pace of innovation in the industry has been most rapid. In that time frame the large U.S. corporations--based in…
Price Controls or Control through Prices? Regulating the Cost and Consumption of Prescription Pharmaceuticals in the UK, 1948–67
Prescribing by Numbers
Patents and the UK pharmaceutical industry between 1945 and the 1970s
The years following the end of World War II saw a rapid increase in the rate of the introduction of new products by the pharmaceutical industry in Europe and North America. Patenting played an increasingly significant role in the industry and the companies, which were investing heavily in research, needed to develop strategies of appropriation to ensure that they recouped the rewards of innovation. This paper explores the use of patents by UK com…
Medicating Modern America
Reviewed by: Medicating Modern America: Prescription Drugs in History Judy Slinn (bio) Medicating Modern America: Prescription Drugs in History. Edited by Andrea Tone and Elizabeth Siegel Watkins. New York: New York University Press, 2007. Pp. vi+262. $70/$22. The exponential growth of the pharmaceutical industry in the second half of the twentieth century has been a significant international phenomenon offering a rich area for exploration by his…
Burroughs Wellcome & Co
Glaxo
The Commonwealth III
The background and the market South Africa provides an interesting case of a market in which Glaxo Laboratories made a considerable effort in the 1940s and 1950s, largely at the instigation of Jephcott and under the influence of his loyalty to the Commonwealth Dominions. At that time British multinational investment in South Africa was particularly successful, but political factors and other local characteristics resulted in a gradual diminution …
Economics (6 works) · Business (5 works) · Engineering (4 works) · Medicine (4 works) · Computer Science (3 works) · History (3 works) · Library science (3 works) · Management (3 works) · Medical History and Innovations (3 works) · Biotechnology (2 works)